Cargando…
Protection of Islet Grafts Through Transforming Growth Factor-β–Induced Tolerogenic Dendritic Cells
In type 1 diabetes, the insulin-producing β-cells are destroyed by the immune system. One way of restoring glucose control is to transplant β-cells from a donor. Although this procedure may restore endogenous insulin production, immunosuppressive treatment is needed to prevent the recipient from rej...
Autores principales: | Thomas, David C., Wong, F. Susan, Zaccone, Paola, Green, E. Allison, Wållberg, Maja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749342/ https://www.ncbi.nlm.nih.gov/pubmed/23715623 http://dx.doi.org/10.2337/db12-1740 |
Ejemplares similares
-
Tolerogenic dendritic cell-based immunotherapy
por: Chang, Kiyuk, et al.
Publicado: (2017) -
TGF-β Suppresses β-Catenin-Dependent Tolerogenic Activation
Program in Dendritic Cells
por: Vander Lugt, Bryan, et al.
Publicado: (2011) -
Regulatory Multitasking of Tolerogenic Dendritic Cells – Lessons Taken from Vitamin D3-Treated Tolerogenic Dendritic Cells
por: Nikolic, Tatjana, et al.
Publicado: (2013) -
Tolerogenic function of Blimp-1 in dendritic cells
por: Kim, Sun Jung, et al.
Publicado: (2011) -
Tolerogenic function of Blimp-1 in dendritic cells
por: Kim, Sun Jung, et al.
Publicado: (2012)